HEADER TRANSPORT 10-JAN-06 2CBZ TITLE STRUCTURE OF THE HUMAN MULTIDRUG RESISTANCE PROTEIN 1 NUCLEOTIDE TITLE 2 BINDING DOMAIN 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NBD1 DOMAIN, RESIDUES 642-871; COMPND 5 SYNONYM: MRP1, ATP-BINDING CASSETTE SUB- FAMILY C MEMBER 1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ABC PROTEINS, MRP1/ABCC1, NUCLEOTIDE-BINDING DOMAIN, ATP-BINDING, KEYWDS 2 HYDROLYSIS, TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR O.RAMAEN,N.LEULLIOT,C.SIZUN,N.ULRYCK,O.PAMLARD,J.-Y.LALLEMAND,H.VAN AUTHOR 2 TILBEURGH,E.JACQUET REVDAT 4 13-DEC-23 2CBZ 1 LINK REVDAT 3 24-FEB-09 2CBZ 1 VERSN REVDAT 2 14-JUN-06 2CBZ 1 JRNL REVDAT 1 17-MAY-06 2CBZ 0 JRNL AUTH O.RAMAEN,N.LEULLIOT,C.SIZUN,N.ULRYCK,O.PAMLARD, JRNL AUTH 2 J.-Y.LALLEMAND,H.VAN TILBEURGH,E.JACQUET JRNL TITL STRUCTURE OF THE HUMAN MULTIDRUG RESISTANCE PROTEIN 1 JRNL TITL 2 NUCLEOTIDE BINDING DOMAIN 1 BOUND TO MG(2+)/ATP REVEALS A JRNL TITL 3 NON-PRODUCTIVE CATALYTIC SITE. JRNL REF J.MOL.BIOL. V. 359 940 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16697012 JRNL DOI 10.1016/J.JMB.2006.04.005 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 47194 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.161 REMARK 3 R VALUE (WORKING SET) : 0.160 REMARK 3 FREE R VALUE : 0.187 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2490 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3489 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 203 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1752 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 284 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.06000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : -0.09000 REMARK 3 B12 (A**2) : 0.03000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.065 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.060 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.037 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.145 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1817 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2472 ; 1.194 ; 1.992 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 229 ; 4.912 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 74 ;30.121 ;24.459 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 302 ;10.596 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;19.740 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 282 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1350 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 842 ; 0.198 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1269 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 219 ; 0.106 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 37 ; 0.149 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 19 ; 0.109 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1167 ; 0.915 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1834 ; 1.450 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 733 ; 2.235 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 638 ; 3.513 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2CBZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1290027146. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49722 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 14.10 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1XMI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG1000, 0.1M MG ACETATE PH 5.6, PH REMARK 280 8.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 21.53733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.07467 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 MAY PARTICIPATE DIRECTLY IN THE ACTIVE TRANSPORT OF REMARK 400 DRUGS INTO SUBCELLULAR ORGANELLES OR INFLUENCE DRUG REMARK 400 DISTRIBUTION INDIRECTLY. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 641 REMARK 465 HIS A 873 REMARK 465 HIS A 874 REMARK 465 HIS A 875 REMARK 465 HIS A 876 REMARK 465 HIS A 877 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 872 CA C O CB CG ND1 CD2 REMARK 470 HIS A 872 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2222 O HOH A 2223 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 654 117.33 -162.62 REMARK 500 ASP A 720 -177.82 -172.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1872 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 685 OG REMARK 620 2 GLN A 713 OE1 84.0 REMARK 620 3 ATP A1873 O1G 177.8 95.9 REMARK 620 4 ATP A1873 O2B 87.9 169.2 92.4 REMARK 620 5 HOH A2188 O 88.1 89.2 89.8 97.7 REMARK 620 6 HOH A2280 O 88.2 83.9 93.9 88.7 172.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A1872 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A1873 REMARK 999 REMARK 999 SEQUENCE REMARK 999 ASN642 TO SER871 DOMAIN, 6X HIS C-TERMINAL TAG DBREF 2CBZ A 641 641 PDB 2CBZ 2CBZ 641 641 DBREF 2CBZ A 642 871 UNP P33527 MRP1_HUMAN 642 871 DBREF 2CBZ A 872 877 PDB 2CBZ 2CBZ 872 877 SEQRES 1 A 237 MET ASN SER ILE THR VAL ARG ASN ALA THR PHE THR TRP SEQRES 2 A 237 ALA ARG SER ASP PRO PRO THR LEU ASN GLY ILE THR PHE SEQRES 3 A 237 SER ILE PRO GLU GLY ALA LEU VAL ALA VAL VAL GLY GLN SEQRES 4 A 237 VAL GLY CYS GLY LYS SER SER LEU LEU SER ALA LEU LEU SEQRES 5 A 237 ALA GLU MET ASP LYS VAL GLU GLY HIS VAL ALA ILE LYS SEQRES 6 A 237 GLY SER VAL ALA TYR VAL PRO GLN GLN ALA TRP ILE GLN SEQRES 7 A 237 ASN ASP SER LEU ARG GLU ASN ILE LEU PHE GLY CYS GLN SEQRES 8 A 237 LEU GLU GLU PRO TYR TYR ARG SER VAL ILE GLN ALA CYS SEQRES 9 A 237 ALA LEU LEU PRO ASP LEU GLU ILE LEU PRO SER GLY ASP SEQRES 10 A 237 ARG THR GLU ILE GLY GLU LYS GLY VAL ASN LEU SER GLY SEQRES 11 A 237 GLY GLN LYS GLN ARG VAL SER LEU ALA ARG ALA VAL TYR SEQRES 12 A 237 SER ASN ALA ASP ILE TYR LEU PHE ASP ASP PRO LEU SER SEQRES 13 A 237 ALA VAL ASP ALA HIS VAL GLY LYS HIS ILE PHE GLU ASN SEQRES 14 A 237 VAL ILE GLY PRO LYS GLY MET LEU LYS ASN LYS THR ARG SEQRES 15 A 237 ILE LEU VAL THR HIS SER MET SER TYR LEU PRO GLN VAL SEQRES 16 A 237 ASP VAL ILE ILE VAL MET SER GLY GLY LYS ILE SER GLU SEQRES 17 A 237 MET GLY SER TYR GLN GLU LEU LEU ALA ARG ASP GLY ALA SEQRES 18 A 237 PHE ALA GLU PHE LEU ARG THR TYR ALA SER HIS HIS HIS SEQRES 19 A 237 HIS HIS HIS HET MG A1872 1 HET ATP A1873 31 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 2 MG MG 2+ FORMUL 3 ATP C10 H16 N5 O13 P3 FORMUL 4 HOH *284(H2 O) HELIX 1 1 GLY A 683 LEU A 692 1 10 HELIX 2 2 LEU A 722 PHE A 728 1 7 HELIX 3 3 PRO A 735 CYS A 744 1 10 HELIX 4 4 LEU A 746 GLU A 751 1 6 HELIX 5 5 SER A 755 ARG A 758 5 4 HELIX 6 6 SER A 769 ASN A 785 1 17 HELIX 7 7 ASP A 799 VAL A 810 1 12 HELIX 8 8 TYR A 831 VAL A 835 5 5 HELIX 9 9 SER A 851 ASP A 859 1 9 HELIX 10 10 GLY A 860 TYR A 869 1 10 SHEET 1 AA 3 LEU A 661 ILE A 668 0 SHEET 2 AA 3 ILE A 644 THR A 652 -1 O ILE A 644 N ILE A 668 SHEET 3 AA 3 ASP A 696 ILE A 704 -1 O ASP A 696 N THR A 652 SHEET 1 AB 6 VAL A 708 VAL A 711 0 SHEET 2 AB 6 ILE A 788 ASP A 792 1 O ILE A 788 N ALA A 709 SHEET 3 AB 6 THR A 821 VAL A 825 1 O THR A 821 N TYR A 789 SHEET 4 AB 6 LEU A 673 VAL A 677 1 O VAL A 674 N LEU A 824 SHEET 5 AB 6 VAL A 837 SER A 842 1 O VAL A 837 N ALA A 675 SHEET 6 AB 6 LYS A 845 GLY A 850 -1 O LYS A 845 N SER A 842 SHEET 1 AC 2 ASP A 720 SER A 721 0 SHEET 2 AC 2 GLU A 760 ILE A 761 -1 O ILE A 761 N ASP A 720 LINK OG SER A 685 MG MG A1872 1555 1555 2.08 LINK OE1 GLN A 713 MG MG A1872 1555 1555 2.12 LINK MG MG A1872 O1G ATP A1873 1555 1555 1.96 LINK MG MG A1872 O2B ATP A1873 1555 1555 2.08 LINK MG MG A1872 O HOH A2188 1555 1555 2.08 LINK MG MG A1872 O HOH A2280 1555 1555 2.13 CISPEP 1 GLU A 734 PRO A 735 0 3.88 SITE 1 AC1 5 SER A 685 GLN A 713 ATP A1873 HOH A2188 SITE 2 AC1 5 HOH A2280 SITE 1 AC2 24 TRP A 653 THR A 660 VAL A 680 GLY A 681 SITE 2 AC2 24 CYS A 682 GLY A 683 LYS A 684 SER A 685 SITE 3 AC2 24 SER A 686 GLN A 713 LYS A 764 MG A1872 SITE 4 AC2 24 HOH A2084 HOH A2161 HOH A2188 HOH A2275 SITE 5 AC2 24 HOH A2276 HOH A2277 HOH A2278 HOH A2279 SITE 6 AC2 24 HOH A2280 HOH A2281 HOH A2282 HOH A2283 CRYST1 65.560 65.560 64.612 90.00 90.00 120.00 P 31 3 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015253 0.008806 0.000000 0.00000 SCALE2 0.000000 0.017613 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015477 0.00000